Heparin-induced prolongation of partial thromboplastin time after thrombolysis: Relation to coronary artery patency
Authors:
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1990
- Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.Circulation, 1990
- Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.Circulation, 1990
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction.Circulation, 1989
- Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activityBlood, 1988
- Improved survival up to four years after early coronary thrombolysisThe American Journal of Cardiology, 1988
- Role of heparin after intravenous thrombolytic therapy for acute myocardial infarctionThe American Journal of Cardiology, 1987
- IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985